A novel liquid biopsy technology is set to advance cancer diagnostics and monitoring by overcoming the long-standing ...

The global automated nucleic acid extraction market size was valued at US$ 3.6 Bn in 2025 and is projected to reach US$ 11.7 ...

American Journal of Transplantation position paper also highlights value of absolute quantification of dd-cfDNA as a diagnostic marker, a key ...

A novel liquid biopsy technology is set to advance cancer diagnostics and monitoring by overcoming the long-standing challenge of simultaneously achieving high sensitivity, broad coverage, and simple ...

Across all included studies, AI-based diagnostic systems demonstrated high overall accuracy. When measured against expert ...

Bayer, a leading company in key areas of radiology and cardiology, and Attralus, Inc. (Attralus), a clinical stage biopharmaceutical company focused on developing medicines and diagnostics for ...

With advancing food allergy research and emerging therapies, new allergy testing requirements arise. In this context, ...

Project LiBRha aims to improve pediatric STS diagnosis and treatment through comprehensive molecular testing and liquid biopsy integration. The initiative involves 18 centers and partnerships with the ...

A blood test, combined with an ultrathin material derived from graphite, could significantly advance efforts to detect ...

Genomate Health, the U.S.-based precision medicine company transforming cancer care through its proprietary computational reasoning technology, today announced its acquisition of Oncompass Medicine.